Indonesia approves AstraZeneca emergency vaccine


© Reuters. Delivery of the COVID-19 vaccine arrives at Soekarno-Hatta International Airport


JAKARTA (Reuters) – Indonesia has approved AstraZeneca’s (NASDAQ 🙂 COVID-19 vaccine for emergency use, Penny K. Lukito, chief of the country’s Food and Drug Administration, told a news conference on Tuesday.

More than a million doses of the vaccine arrived late Monday via COVAX’s global vaccine alliance program. So far, around 38 million doses of a vaccine manufactured by China’s Sinovac Biotech have arrived in the Southeast Asian country, some of which were used in a mass vaccination from January.

Disclaimer: Fusion Media would like to remind you that the information contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges, but by market makers. As a result, prices may not be accurate and may differ from the actual market price. This means that the prices are indicative and not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading losses you may incur using this information.

Fusion Media or anyone involved with Fusion Media assumes no liability for any loss or damage caused by reliance on the information contained on this website, such as data, offers, charts and buy / sell signals. Please inform yourself comprehensively about the risks and costs associated with trading in the financial markets. This is one of the riskiest forms of investment possible.

Comments are closed.